Loading…
Data as of .
| Company | Industry | Market cap | 1M | 6M | Revenue growth | Op. margin | Fwd P/E |
|---|---|---|---|---|---|---|---|
| Lilly (Eli) LLY | Pharmaceuticals: Major | $1.27T | +16% | +43% | +46% | 51% | 28.9× |
| Johnson & Johnson JNJ | Pharmaceuticals: Major | $665B | +8% | +26% | +8% | 26% | 24.5× |
| AbbVie ABBV | Pharmaceuticals: Major | $515B | +7% | +45% | +11% | 36% | 18.4× |
| Merck & MRK | Pharmaceuticals: Major | $362B | +3% | +33% | +5% | 18% | 17.4× |
| UnitedHealth UNH | Managed Health Care | $353B | +6% | +4% | +3% | 5% | 17.4× |
| Thermo Fisher Scientific TMO | Medical Specialties | $257B | +7% | +50% | +8% | 19% | 25.8× |
| Amgen AMGN | Biotechnology | $249B | +13% | +40% | +9% | 36% | 18.9× |
| Gilead Sciences GILD | Biotechnology | $207B | +13% | +28% | +7% | 38% | 19.3× |
| Abbott Laboratories ABT | Medical Specialties | $190B | +12% | +30% | +10% | 14% | 18.8× |
| Pfizer PFE | Pharmaceuticals: Major | $168B | +6% | +14% | +1% | 26% | 10.4× |
| Danaher DHR | Medical Specialties | $162B | +6% | +35% | +6% | 21% | 25.3× |
| Intuitive Surgical ISRG | Medical Specialties | $157B | +9% | +1% | +20% | 32% | 37.5× |
| Vertex Pharmaceuticals VRTX | Pharmaceuticals: Major | $139B | +9% | +27% | +11% | 35% | 29.0× |
| Medtronic MDT | Medical Specialties | $130B | +16% | +35% | +10% | 20% | 16.9× |
| Bristol Myers Squibb BMY | Pharmaceuticals: Major | $127B | +4% | +12% | +4% | 33% | 9.7× |
| Stryker SYK | Medical Specialties | $124B | +18% | +14% | +8% | 25% | 20.4× |
| McKesson MCK | Medical Distributors | $124B | +14% | +44% | +9% | 2% | 21.8× |
| CVS Health CVS | Drugstore Chains | $107B | -4% | -7% | +7% | 4% | 9.9× |
| HCA Healthcare HCA | Hospital/Nursing Management | $103B | +11% | +14% | +6% | 15% | 16.2× |
| Moderna MRNA | Biotechnology | $101B | +3% | +43% | -28% | -149% | n/a |
| Regeneron Pharmaceuticals REGN | Pharmaceuticals: Major | $93.5B | +22% | +27% | +19% | 30% | 11.3× |
| Elevance Health ELV | Managed Health Care | $92.0B | +6% | +13% | +4% | 4% | 14.8× |
| Cigna CI | Managed Health Care | $77.6B | +4% | +3% | +8% | 4% | 9.0× |
| Cencora COR | Medical Distributors | $63.7B | +4% | +28% | +5% | 1% | 16.9× |
| Cardinal Health CAH | Medical Distributors | $62.9B | +14% | +48% | +14% | 1% | 20.8× |
| Boston Scientific BSX | Medical Specialties | $62.0B | +2% | -21% | +9% | 21% | 13.8× |
| Edwards Lifesciences EW | Medical Specialties | $58.9B | +21% | +28% | +15% | 29% | 31.4× |
| Becton Dickinson BDX | Medical Specialties | $57.7B | +16% | +43% | -3% | 15% | 16.0× |
| argenx SE Sponsored ADR ARGX | Biotechnology | $57.5B | +13% | +19% | +71% | 29% | n/a |
| Idexx Laboratories IDXX | Medical Specialties | $53.3B | +32% | +21% | +12% | 32% | 41.5× |
| Medline MDLN | Medical Specialties | $52.1B | +11% | 0% | +12% | 6% | 26.1× |
| Humana HUM | Managed Health Care | $52.1B | +12% | +58% | +18% | 2% | 32.9× |
| Teva Pharmaceutical Industries Limited Sponsored ADR TEVA | Pharmaceuticals: Generic | $49.7B | +9% | +19% | -4% | 19% | 15.1× |
| Agilent Technologies A | Medical Specialties | $49.3B | +4% | +51% | +9% | 24% | 26.6× |
| Veeva Systems VEEV | Packaged Software | $49.2B | +7% | +83% | +16% | 30% | 31.4× |
| Waters WAT | Medical Specialties | $45.0B | +7% | +29% | +81% | 10% | 28.6× |
| Iqvia IQV | Biotechnology | $44.8B | +5% | +52% | +9% | 14% | 19.7× |
| Natera NTRA | Biotechnology | $44.8B | -20% | +60% | +38% | -11% | n/a |
| Revolution Medicines RVMD | Pharmaceuticals: Other | $41.2B | +2% | +36% | n/a | n/a | n/a |
| Royalty Pharma RPRX | Pharmaceuticals: Major | $38.8B | +20% | +33% | +11% | 66% | 11.3× |
| GE HealthCare GEHC | Medical Specialties | $37.2B | +28% | +30% | +7% | 14% | 15.4× |
| Biogen BIIB | Pharmaceuticals: Major | $36.7B | +14% | +28% | +2% | 17% | 16.8× |
| Centene CNC | Managed Health Care | $34.5B | +8% | +25% | +10% | 1% | 13.3× |
| Mettler Toledo MTD | Medical Specialties | $34.5B | +13% | +53% | +7% | 28% | 33.9× |
| ResMed RMD | Medical Specialties | $33.1B | +4% | +14% | +9% | 34% | 19.1× |
| Zoetis ZTS | Pharmaceuticals: Major | $32.8B | +9% | -4% | +1% | 38% | 12.8× |
| Illumina ILMN | Medical Specialties | $32.2B | -19% | +50% | +6% | 21% | 35.7× |
| Labcorp LH | Medical/Nursing Services | $29.8B | +17% | +45% | +6% | 11% | 19.0× |
| Dexcom DXCM | Medical Specialties | $29.6B | -6% | +31% | +13% | 24% | 27.0× |
| Quest Diagnostics DGX | Services to the Health Industry | $28.1B | +11% | +36% | +9% | 15% | 22.0× |
| Roivant Sciences ROIV | Pharmaceuticals: Major | $28.1B | +14% | +36% | -68% | -18,146% | n/a |
| West Pharmaceutical Services WST | Medical Specialties | $27.9B | +10% | +23% | +13% | 23% | 39.8× |
| Insmed INSM | Pharmaceuticals: Major | $25.1B | +14% | -16% | +240% | -42% | n/a |
| Steris STE | Medical Specialties | $24.6B | +20% | +22% | +8% | 20% | 21.4× |
| Incyte INCY | Pharmaceuticals: Major | $24.4B | +6% | +21% | +25% | 12% | 15.4× |
| United Therapeutics UTHR | Biotechnology | $24.1B | +5% | -1% | +2% | 44% | 22.0× |
| Viatris VTRS | Pharmaceuticals: Major | $22.9B | +14% | +17% | +5% | 10% | 7.5× |
| BioNTech SE Sponsored ADR BNTX | Biotechnology | $22.8B | -5% | -7% | -1% | -38% | n/a |
| Tenet Healthcare THC | Hospital/Nursing Management | $22.5B | +9% | +49% | +6% | 17% | 14.0× |
| Alnylam Pharmaceuticals ALNY | Pharmaceuticals: Major | $20.9B | -31% | -47% | +56% | 20% | 22.2× |
| Guardant Health GH | Medical Specialties | $20.2B | -9% | +58% | +43% | -40% | n/a |
| Zimmer Biomet ZBH | Medical Specialties | $20.1B | +19% | +29% | +7% | 16% | 12.0× |
| Medpace MEDP | Miscellaneous Commercial Services | $18.3B | +8% | +54% | +20% | 21% | 33.9× |
| Revvity RVTY | Medical Specialties | $17.3B | +2% | +54% | +5% | 15% | 26.7× |
| Exelixis EXEL | Pharmaceuticals: Major | $17.0B | +18% | +44% | +9% | 40% | 18.2× |
| Neurocrine Biosciences NBIX | Biotechnology | $16.7B | +17% | +8% | +38% | 25% | 18.2× |
| Charles River Laboratories CRL | Miscellaneous Commercial Services | $16.1B | +13% | +90% | -1% | 15% | 26.6× |
| Ascendis Pharma A/S ASND | Pharmaceuticals: Major | $16.0B | +15% | +8% | +128% | 10% | 40.8× |
| Solventum SOLV | Medical/Nursing Services | $15.4B | +5% | +23% | -1% | 8% | 12.2× |
| ICON ICLR | Miscellaneous Commercial Services | $15.3B | +24% | +64% | +1% | 10% | 18.2× |
| Jazz Pharmaceuticals Public JAZZ | Pharmaceuticals: Major | $15.1B | +6% | +4% | +13% | 25% | 8.9× |
| BridgeBio Pharma BBIO | Biotechnology | $14.5B | +14% | +10% | +167% | -37% | n/a |
| Encompass Health EHC | Medical/Nursing Services | $13.5B | +12% | +30% | +9% | 18% | 20.5× |
| BrightSpring Health Services BTSG | Medical/Nursing Services | $13.4B | +5% | +22% | +23% | 4% | 28.3× |
| Baxter International BAX | Medical Specialties | $13.3B | +8% | +43% | +5% | 6% | 12.6× |
| Glaukos GKOS | Medical Specialties | $13.3B | +39% | +68% | +47% | -9% | 155.4× |
| Summit Therapeutics SMMT | Biotechnology | $13.1B | -5% | -10% | n/a | n/a | n/a |
| Elanco Animal Health ELAN | Biotechnology | $12.9B | +14% | +9% | +12% | 7% | 21.8× |
| Penumbra PEN | Medical Specialties | $12.6B | +1% | -1% | +17% | 12% | 54.9× |
| DaVita DVA | Medical/Nursing Services | $12.0B | +8% | -4% | +6% | 15% | 11.9× |
| Cooper Companies (The) COO | Medical Specialties | $11.9B | +15% | +4% | +5% | 19% | 13.8× |
| Align Technology ALGN | Medical Specialties | $11.8B | +18% | -2% | +4% | 19% | 13.9× |
| Halozyme Therapeutics HALO | Biotechnology | $11.8B | -6% | +62% | +41% | 57% | 10.7× |
| Universal Health Services UHS | Hospital/Nursing Management | $11.5B | +11% | +15% | +8% | 11% | 8.7× |
| Bio-Techne TECH | Biotechnology | $11.4B | 0% | +51% | 0% | 22% | 35.9× |
| Kymera Therapeutics KYMR | Biotechnology | $11.2B | +21% | +53% | +134% | -396% | n/a |
| Repligen RGEN | Pharmaceuticals: Major | $11.1B | +6% | +41% | +14% | 9% | 71.3× |
| Molina Healthcare MOH | Managed Health Care | $10.9B | +7% | +12% | -1% | 1% | 25.0× |
| BioMarin Pharmaceutical BMRN | Biotechnology | $10.9B | +2% | +4% | +20% | 19% | 10.3× |
| Ensign ENSG | Medical/Nursing Services | $10.6B | +6% | +6% | +17% | 9% | 21.1× |
| Avantor AVTR | Medical Specialties | $10.5B | +1% | +86% | +1% | 8% | 17.7× |
| Qiagen QGEN | Medical Specialties | $10.4B | +13% | +52% | +3% | 25% | 19.8× |
| Bio-Rad Laboratories BIO | Medical Specialties | $10.3B | +6% | +50% | +1% | 9% | 35.7× |
| Insulet PODD | Medical Specialties | $10.2B | +9% | -5% | +26% | 18% | 19.5× |
| Vaxcyte PCVX | Biotechnology | $10.1B | -2% | +21% | n/a | n/a | n/a |
| Spyre Therapeutics SYRE | Pharmaceuticals: Major | $9.86B | +30% | +38% | n/a | n/a | n/a |
| Globus Medical GMED | Medical Specialties | $9.54B | -3% | -9% | +20% | 22% | 14.1× |
| Henry Schein HSIC | Medical Distributors | $9.51B | +2% | +22% | +6% | 6% | 14.8× |
| Bruker BRKR | Medical Specialties | $9.34B | +6% | +39% | +2% | 9% | 26.2× |
| Madrigal Pharmaceuticals MDGL | Pharmaceuticals: Major | $9.28B | -16% | -22% | +93% | -11% | 79.5× |
| TG Therapeutics TGTX | Pharmaceuticals: Major | $9.16B | +12% | +40% | +76% | 17% | 30.9× |
| ImmunityBio IBRX | Pharmaceuticals: Major | $9.15B | -13% | +1% | +193% | -152% | n/a |
| Krystal Biotech KRYS | Biotechnology | $8.92B | -8% | -2% | +26% | 48% | 34.7× |
| Protagonist Therapeutics PTGX | Pharmaceuticals: Major | $8.54B | -6% | +33% | +35% | 21% | 48.4× |
| Oscar Health OSCR | Managed Health Care | $8.38B | -7% | +44% | +43% | 4% | 14.0× |
| Arrowhead Pharmaceuticals ARWR | Biotechnology | $8.22B | -4% | -20% | +17% | -34% | n/a |
| Corcept Therapeutics CORT | Pharmaceuticals: Major | $7.96B | -39% | +39% | +30% | 12% | 16.4× |
| Twist Bioscience TWST | Biotechnology | $7.95B | -21% | +112% | +19% | -32% | n/a |
| PACS PACS | Hospital/Nursing Management | $7.87B | +13% | +48% | +11% | 8% | 19.2× |
| Rhythm Pharmaceuticals RYTM | Pharmaceuticals: Major | $7.78B | +25% | +19% | +61% | -67% | n/a |
| Praxis Precision Medicines PRAX | Pharmaceuticals: Major | $7.75B | +5% | -16% | -100% | n/a | n/a |
| 10x Genomics TXG | Biotechnology | $7.72B | -23% | +174% | -4% | -14% | n/a |
| Alkermes Public ALKS | Pharmaceuticals: Major | $7.71B | +14% | +31% | +15% | 5% | n/a |
| Cytokinetics CYTK | Pharmaceuticals: Major | $7.46B | -13% | -30% | -21% | -1,046% | n/a |
| Kiniksa Pharmaceuticals International KNSA | Pharmaceuticals: Major | $7.37B | +19% | +60% | +58% | 14% | 61.7× |
| Caris Life Sciences CAI | Biotechnology | $7.13B | -8% | +56% | +85% | 15% | 86.1× |
| Amneal Pharmaceuticals AMRX | Pharmaceuticals: Major | $7.01B | +2% | +53% | +9% | 17% | 17.7× |
| Axsome Therapeutics AXSM | Biotechnology | $6.96B | -22% | -39% | +54% | -19% | 75.5× |
| Chemed CHE | Hospital/Nursing Management | $6.87B | +6% | +24% | +5% | 14% | 19.5× |
| Oruka Therapeutics ORKA | Pharmaceuticals: Major | $6.81B | +33% | +59% | n/a | n/a | n/a |
| CG Oncology CGON | Biotechnology | $6.74B | +20% | +9% | +1,030% | -4,056% | n/a |
| Lantheus LNTH | Medical Specialties | $6.57B | 0% | +8% | +2% | 19% | 17.5× |
| Ionis Pharmaceuticals IONS | Pharmaceuticals: Major | $6.55B | -9% | -48% | -7% | -68% | n/a |
| Teleflex TFX | Medical Specialties | $6.39B | +21% | +13% | -14% | 11% | 16.8× |
| Immunovant IMVT | Biotechnology | $6.31B | +1% | +5% | n/a | n/a | n/a |
| Kodiak Sciences KOD | Biotechnology | $6.24B | +5% | +142% | n/a | n/a | n/a |
| Belite Bio, Inc. ADR BLTE | Pharmaceuticals: Major | $6.20B | +1% | 0% | n/a | n/a | n/a |
| Ligand Pharmaceuticals LGND | Pharmaceuticals: Major | $6.12B | +4% | +38% | +1% | 14% | 28.0× |
| Mirum Pharmaceuticals MIRM | Pharmaceuticals: Major | $6.12B | +15% | -13% | +42% | -21% | n/a |
| Hims & Hers Health HIMS | Medical/Nursing Services | $6.07B | -7% | -8% | +28% | 0% | 128.9× |
| RadNet RDNT | Medical/Nursing Services | $5.98B | +11% | +31% | +19% | 5% | 129.7× |
| Veradermics MANE | Pharmaceuticals: Major | $5.80B | +10% | +31% | n/a | n/a | n/a |
| Scholar Rock SRRK | Biotechnology | $5.72B | +11% | -3% | n/a | n/a | n/a |
| Cogent Biosciences COGT | Biotechnology | $5.49B | +5% | -9% | n/a | n/a | n/a |
| PTC Therapeutics PTCT | Pharmaceuticals: Major | $5.47B | +5% | -11% | -35% | 22% | 34.8× |
| Haemonetics HAE | Medical Specialties | $5.46B | 0% | +118% | 0% | 18% | 21.6× |
| Supernus Pharmaceuticals SUPN | Pharmaceuticals: Major | $5.43B | -39% | -49% | +16% | 45% | 6.7× |
| GRAIL GRAL | Medical Specialties | $5.42B | +9% | +67% | +23% | -323% | n/a |
| Concentra Group Holdings Parent CON | Medical/Nursing Services | $5.38B | +15% | +75% | +14% | 17% | 24.5× |
| BillionToOne BLLN | Medical/Nursing Services | $5.38B | +19% | +54% | +90% | 11% | 144.4× |
| Lifestance Health LFST | Medical/Nursing Services | $5.26B | +14% | +79% | +20% | 5% | 62.6× |
| Merit Medical Systems MMSI | Medical Specialties | $5.23B | +2% | +42% | +9% | 14% | 19.4× |
| Erasca ERAS | Pharmaceuticals: Major | $5.04B | -7% | +42% | n/a | n/a | n/a |
| LivaNova LIVN | Medical Specialties | $4.96B | +19% | +25% | +12% | 13% | 19.9× |
| Edgewise Therapeutics EWTX | Biotechnology | $4.89B | +15% | +28% | n/a | n/a | n/a |
| CRISPR Therapeutics CRSP | Biotechnology | $4.86B | -1% | -9% | -34% | -2,059% | n/a |
| Dianthus Therapeutics DNTH | Biotechnology | $4.81B | +4% | -1% | -61% | -11,441% | n/a |
| Travere Therapeutics TVTX | Pharmaceuticals: Major | $4.76B | -5% | +16% | +49% | -3% | 16.9× |
| Option Care Health OPCH | Medical/Nursing Services | $4.74B | +2% | +54% | +4% | 6% | 15.6× |
| MiniMed MMED | Medical Specialties | $4.70B | -16% | +44% | +14% | 14% | 25.5× |
| Sotera Health SHC | Medical Specialties | $4.57B | -10% | +1% | +7% | 37% | 15.4× |
| Legend Biotech Corp. Sponsored ADR LEGN | Pharmaceuticals: Major | $4.53B | +25% | -17% | +60% | -4% | 64.5× |
| Definium Therapeutics DFTX | Pharmaceuticals: Major | $4.47B | -3% | +51% | n/a | n/a | n/a |
| Adaptive Biotechnologies ADPT | Biotechnology | $4.47B | +7% | +103% | +50% | -12% | n/a |
| ICU Medical ICUI | Medical Specialties | $4.30B | +10% | +36% | -9% | 7% | 19.5× |
| Integer ITGR | Medical Specialties | $4.30B | 0% | +44% | 0% | 9% | 18.8× |
| CareDx CDNA | Medical Specialties | $4.13B | +26% | +260% | +39% | 1% | 53.2× |
| Relay Therapeutics RLAY | Biotechnology | $4.08B | +7% | +46% | +24% | -2,999% | n/a |
| Envista NVST | Medical Specialties | $4.04B | +11% | +4% | +12% | 11% | 15.6× |
| Liquidia LQDA | Pharmaceuticals: Major | $3.97B | +58% | +5% | +2,234% | 37% | 32.9× |
| Pulse Biosciences PLSE | Medical Specialties | $3.87B | +7% | +179% | n/a | -7,008% | n/a |
| AbCellera Biologics ABCL | Biotechnology | $3.85B | -5% | +149% | +101% | -340% | n/a |
| Xenon Pharmaceuticals XENE | Pharmaceuticals: Major | $3.79B | -9% | +4% | -100% | n/a | n/a |
| Stevanato STVN | Medical Specialties | $3.70B | -29% | -26% | +12% | 18% | 19.3× |
| Amylyx Pharmaceuticals AMLX | Pharmaceuticals: Major | $3.70B | +30% | +97% | +100% | n/a | n/a |
| ACADIA Pharmaceuticals ACAD | Pharmaceuticals: Major | $3.66B | +8% | -5% | +12% | 8% | 21.5× |
| Organon & OGN | Pharmaceuticals: Major | $3.64B | +1% | +4% | -3% | 20% | 4.0× |
| Iovance Biotherapeutics IOVA | Biotechnology | $3.64B | 0% | +64% | +35% | -91% | n/a |
| Tango Therapeutics TNGX | Biotechnology | $3.63B | -5% | -7% | +121% | -253% | n/a |
| Enliven Therapeutics ELVN | Biotechnology | $3.62B | +22% | +21% | n/a | n/a | n/a |
| Parabilis Medicines PBLS | Pharmaceuticals: Major | $3.52B | +2% | n/a | n/a | n/a | n/a |
| Disc Medicine IRON | Biotechnology | $3.50B | +30% | +16% | n/a | n/a | n/a |
| Acadia Healthcare ACHC | Medical/Nursing Services | $3.44B | +30% | +47% | +4% | 10% | 18.7× |
| Viking Therapeutics VKTX | Pharmaceuticals: Major | $3.42B | -3% | -17% | n/a | n/a | n/a |
| Tarsus Pharmaceuticals TARS | Pharmaceuticals: Major | $3.38B | -5% | +12% | +86% | -10% | n/a |
| Dyne Therapeutics DYN | Biotechnology | $3.37B | +10% | +3% | n/a | n/a | n/a |
| National HealthCare NHC | Hospital/Nursing Management | $3.27B | -7% | +11% | +7% | -8% | n/a |
| Celcuity CELC | Medical Specialties | $3.27B | -2% | -49% | n/a | n/a | n/a |
| Viridian Therapeutics VRDN | Pharmaceuticals: Major | $3.23B | +55% | +72% | -63% | -1,781% | n/a |
| Denali Therapeutics DNLI | Biotechnology | $3.22B | +8% | +2% | n/a | -2,488% | n/a |
| Arcutis Biotherapeutics ARQT | Pharmaceuticals: Major | $3.21B | +4% | +21% | +76% | 7% | 37.9× |
| TransMedics TMDX | Medical Specialties | $3.06B | +12% | +30% | +26% | 12% | 48.5× |
| IDEAYA Biosciences IDYA | Pharmaceuticals: Major | $3.02B | -13% | +10% | -83% | -1,267% | n/a |
| Surgery Partners SGRY | Hospital/Nursing Management | $2.99B | +70% | +61% | +4% | 14% | 62.5× |
| Axogen AXGN | Medical Specialties | $2.99B | +38% | +19% | +24% | -5% | 76.5× |
| AtriCure ATRC | Medical Specialties | $2.98B | +11% | +123% | +14% | 3% | 220.7× |
| iRhythm IRTC | Medical Specialties | $2.97B | -12% | -25% | +26% | 1% | 182.6× |
| Aveanna Healthcare AVAH | Medical/Nursing Services | $2.89B | +8% | +97% | +20% | 11% | 15.4× |
| ADMA Biologics ADMA | Biotechnology | $2.85B | +23% | +56% | +8% | 42% | 15.7× |
| Vericel VCEL | Pharmaceuticals: Major | $2.80B | +36% | +63% | +23% | 6% | 76.2× |
| Xeris Biopharma XERS | Biotechnology | $2.77B | +49% | +133% | +36% | 11% | 67.9× |
| Beam Therapeutics BEAM | Biotechnology | $2.73B | +7% | -18% | +163% | -268% | n/a |
| Progyny PGNY | Miscellaneous Commercial Services | $2.67B | +25% | +47% | +6% | 9% | 22.7× |
| Xencor XNCR | Biotechnology | $2.66B | +46% | +178% | -29% | -206% | n/a |
| Regencell Bioscience RGC | Pharmaceuticals: Major | $2.61B | -31% | -82% | n/a | n/a | n/a |
| Arcus Biosciences RCUS | Biotechnology | $2.59B | -23% | -28% | -55% | -415% | n/a |
| Neogen NEOG | Medical Specialties | $2.57B | 0% | +30% | 0% | 0% | 34.6× |
| Palvella Therapeutics PVLA | Biotechnology | $2.53B | +34% | +45% | -100% | n/a | n/a |
| MBX Biosciences MBX | Biotechnology | $2.47B | -4% | +25% | n/a | n/a | n/a |
| Pediatrix Medical MD | Medical/Nursing Services | $2.44B | +19% | +33% | +2% | 12% | 12.9× |
| Ardent Health ARDT | Hospital/Nursing Management | $2.44B | +56% | +71% | +3% | 4% | 14.5× |
| Pharvaris PHVS | Biotechnology | $2.41B | +11% | +14% | n/a | n/a | n/a |
| Celldex Therapeutics CLDX | Biotechnology | $2.35B | +2% | -12% | -97% | -206,220% | n/a |
| Addus HomeCare ADUS | Medical/Nursing Services | $2.32B | +9% | +25% | +12% | 11% | 16.6× |
| Hemab Therapeutics COAG | Biotechnology | $2.29B | +59% | +95% | n/a | n/a | n/a |
| Septerna SEPN | Biotechnology | $2.28B | +32% | +105% | +13,520% | -57% | n/a |
| NewAmsterdam Pharma NAMS | Pharmaceuticals: Major | $2.26B | -11% | -51% | -26% | -900% | n/a |
| Immunome IMNM | Biotechnology | $2.21B | -3% | -17% | -100% | n/a | n/a |
| Aurinia Pharmaceuticals AUPH | Biotechnology | $2.21B | +1% | +8% | +21% | 45% | 19.7× |
| Perrigo PRGO | Pharmaceuticals: Major | $2.20B | +9% | +35% | -4% | 5% | 6.3× |
| Recursion Pharmaceuticals RXRX | Biotechnology | $2.19B | -11% | +6% | +56% | -725% | n/a |
| Biohaven BHVN | Pharmaceuticals: Major | $2.19B | +21% | +47% | n/a | n/a | n/a |
| NeoGenomics NEO | Medical/Nursing Services | $2.18B | +5% | +88% | +11% | -6% | 58.9× |
| Brookdale Senior Living BKD | Hospital/Nursing Management | $2.15B | -17% | -31% | -4% | 5% | 127.7× |
| Vera Therapeutics VERA | Biotechnology | $2.15B | 0% | -18% | n/a | n/a | n/a |
| Fortrea FTRE | Miscellaneous Commercial Services | $2.12B | +8% | +42% | -3% | 2% | 22.8× |
| Zymeworks ZYME | Pharmaceuticals: Major | $2.10B | +17% | +24% | -70% | -419% | 12.0× |
| Vir Biotechnology VIR | Biotechnology | $2.07B | +10% | +34% | +1,496% | -92% | n/a |
| Replimune REPL | Biotechnology | $2.05B | +66% | +547% | n/a | n/a | n/a |
| Trevi Therapeutics TRVI | Biotechnology | $2.04B | +12% | -1% | n/a | n/a | n/a |
| Prestige Consumer Healthcare PBH | Pharmaceuticals: Major | $2.04B | -10% | -18% | -1% | 26% | 9.3× |
| First Tracks Biotherapeutics TRAX | Biotechnology | $2.01B | +50% | +145% | n/a | n/a | n/a |
| Establishment Labs ESTA | Medical Specialties | $2.00B | +11% | -7% | +38% | -7% | n/a |
| BioCryst Pharmaceuticals BCRX | Biotechnology | $1.97B | -7% | -11% | +60% | 42% | 11.6× |
| Maravai Lifesciences MRVI | Biotechnology | $1.95B | +4% | +108% | -3% | -13% | n/a |
| Alamar Biosciences ALMR | Biotechnology | $1.95B | +8% | +17% | +195% | -42% | n/a |
| Veracyte VCYT | Medical Specialties | $1.94B | -45% | -40% | +17% | 17% | 14.9× |
| Harmony Biosciences HRMY | Pharmaceuticals: Major | $1.93B | -16% | +7% | +20% | 22% | 8.6× |
| agilon health AGL | Medical/Nursing Services | $1.90B | +34% | +109% | 0% | -4% | 67.5× |
| Maze Therapeutics MAZE | Pharmaceuticals: Major | $1.90B | +32% | +29% | +700% | -728% | n/a |
| Alvotech ALVO | Biotechnology | $1.90B | -14% | +49% | -12% | 9% | 51.5× |
| DENTSPLY SIRONA XRAY | Medical Specialties | $1.89B | +9% | -14% | -1% | 5% | 7.3× |
| Sarepta Therapeutics SRPT | Pharmaceuticals: Major | $1.88B | -2% | -11% | -20% | -3% | n/a |
| GeneDx WGS | Medical/Nursing Services | $1.86B | -8% | +53% | +25% | -12% | 98.7× |
| Inspire Medical Systems INSP | Medical Specialties | $1.85B | -4% | +45% | 0% | 2% | 45.4× |
| LeMaitre Vascular LMAT | Medical Specialties | $1.85B | +2% | -25% | +12% | 29% | 26.2× |
| Zenas BioPharma ZBIO | Biotechnology | $1.84B | +8% | +44% | -93% | -27,390% | n/a |
| Novavax NVAX | Biotechnology | $1.78B | -2% | +7% | -62% | -29% | n/a |
| Lycia Therapeutics LYCA | Biotechnology | $1.76B | n/a | n/a | -55% | -593% | n/a |
| Agios Pharmaceuticals AGIO | Pharmaceuticals: Major | $1.76B | -8% | +6% | +141% | -467% | n/a |
| Absci ABSI | Biotechnology | $1.75B | +14% | +72% | -62% | -8,411% | n/a |
| Stoke Therapeutics STOK | Biotechnology | $1.74B | +11% | -19% | -86% | -913% | n/a |
| Azenta AZTA | Medical/Nursing Services | $1.72B | +9% | +104% | +1% | -3% | 103.7× |
| Kestra Medical Technologies KMTS | Medical Specialties | $1.72B | +12% | +37% | +61% | -134% | n/a |
| Personalis PSNL | Medical/Nursing Services | $1.71B | -2% | +164% | -13% | -164% | n/a |
| Astrana Health ASTH | Services to the Health Industry | $1.71B | -4% | -12% | +59% | 3% | 19.3× |
| Butterfly Network BFLY | Medical Specialties | $1.70B | -21% | +53% | +39% | -36% | n/a |
| SELLAS Life Sciences SLS | Pharmaceuticals: Major | $1.70B | -25% | +68% | n/a | n/a | n/a |
| Kailera Therapeutics KLRA | Biotechnology | $1.68B | +30% | -40% | n/a | n/a | n/a |
| Generate Biomedicines GENB | Biotechnology | $1.68B | -7% | -4% | +56% | -737% | n/a |
| Braveheart Bio BRVE | Pharmaceuticals: Major | $1.67B | -3% | n/a | n/a | n/a | n/a |
| Nurix Therapeutics NRIX | Biotechnology | $1.67B | -31% | -7% | +739% | 41% | n/a |
| Eton Pharmaceuticals ETON | Pharmaceuticals: Major | $1.61B | +22% | +236% | +81% | 16% | 27.9× |
| Precigen PGEN | Biotechnology | $1.60B | -41% | +6% | +1,875% | -46% | 6.9× |
| Teladoc Health TDOC | Medical/Nursing Services | $1.60B | +58% | +21% | -2% | -5% | n/a |
| Immunocore Holdings Plc Shs Sponsored American Depositary Shares Repr 1 Sh IMCR | Biotechnology | $1.60B | +7% | +5% | +20% | -5% | n/a |
| Intellia Therapeutics NTLA | Biotechnology | $1.59B | -10% | -19% | +13% | -712% | n/a |
| Sonida Senior Living SNDA | Medical/Nursing Services | $1.58B | -9% | -14% | +49% | -11% | n/a |
| Enovis ENOV | Medical Specialties | $1.57B | +56% | +2% | +5% | 3% | 7.7× |
| NovoCure NVCR | Medical Specialties | $1.55B | -7% | -26% | +13% | -17% | n/a |
| ANI Pharmaceuticals ANIP | Biotechnology | $1.55B | -6% | -18% | +31% | 13% | 7.6× |
| Alignment Healthcare ALHC | Managed Health Care | $1.54B | -16% | -59% | +36% | 1% | 1,052.5× |
| CONMED CNMD | Medical Specialties | $1.53B | +14% | +40% | +2% | 2% | 11.1× |
| Ultragenyx Pharmaceutical RARE | Pharmaceuticals: Major | $1.52B | +3% | +22% | +16% | -64% | n/a |
| uniQure QURE | Biotechnology | $1.51B | -4% | -22% | +30% | -1,093% | n/a |
| U.S. Physical Therapy USPH | Medical/Nursing Services | $1.48B | +19% | +68% | +11% | 10% | 30.4× |
| Nuvation Bio NUVB | Biotechnology | $1.46B | -16% | -13% | +1,084% | -81% | n/a |
| Damora Therapeutics DMRA | Pharmaceuticals: Major | $1.46B | +15% | -2% | n/a | n/a | n/a |
| Tyra Bioscience TYRA | Biotechnology | $1.45B | +6% | -38% | n/a | n/a | n/a |
| Pacira Biosciences PCRX | Pharmaceuticals: Major | $1.45B | 0% | +57% | +6% | 4% | 11.8× |
| Structure Therapeutics, Inc. Sponsored ADR GPCR | Pharmaceuticals: Major | $1.45B | -21% | -48% | n/a | n/a | n/a |
| Kardigan KARD | Biotechnology | $1.45B | +9% | n/a | n/a | n/a | n/a |
| Ocular Therapeutix OCUL | Pharmaceuticals: Major | $1.45B | -12% | -32% | -8% | -603% | n/a |
| Korsana Biosciences KRSA | Biotechnology | $1.41B | -7% | +43% | -13% | -359% | n/a |
| Taysha Gene Therapies TSHA | Biotechnology | $1.41B | -2% | -36% | -32% | -2,855% | n/a |
| AMN Healthcare Services AMN | Personnel Services | $1.40B | +2% | +25% | +24% | 5% | 46.6× |
| AnaptysBio ANAB | Biotechnology | $1.39B | +1% | -33% | +93% | 56% | 8.6× |
| Innoviva INVA | Pharmaceuticals: Major | $1.38B | -8% | -17% | +18% | 36% | 9.4× |
| Mineralys Therapeutics MLYS | Biotechnology | $1.36B | -32% | -48% | n/a | n/a | n/a |
| LB Pharmaceuticals LBRX | Pharmaceuticals: Major | $1.36B | +21% | +31% | n/a | n/a | n/a |
| Phibro Animal Health PAHC | Pharmaceuticals: Major | $1.34B | -12% | -18% | +17% | 13% | 9.1× |
| Avalyn Pharma AVLN | Pharmaceuticals: Major | $1.29B | +13% | +7% | n/a | n/a | n/a |
| OPKO Health OPK | Medical/Nursing Services | $1.29B | +26% | +52% | -11% | -29% | n/a |
| Lumexa Imaging LMRI | Medical/Nursing Services | $1.29B | +30% | +29% | +8% | 3% | 18.6× |
| GH Research GHRS | Pharmaceuticals: Major | $1.28B | -9% | -13% | n/a | n/a | n/a |
| Nektar Therapeutics NKTR | Pharmaceuticals: Major | $1.27B | -9% | -54% | -27% | -239% | n/a |
| Pennant PNTG | Medical/Nursing Services | $1.27B | -10% | +1% | +38% | 6% | 24.0× |
| Alpha Tau Medical DRTS | Medical Specialties | $1.27B | -2% | +61% | n/a | n/a | n/a |
| STAAR Surgical STAA | Medical Specialties | $1.26B | +13% | -6% | +51% | 18% | 45.8× |
| MannKind MNKD | Pharmaceuticals: Major | $1.25B | +14% | +11% | +30% | 3% | n/a |
| Inhibrx Biosciences INBX | Biotechnology | $1.24B | -9% | -37% | -100% | n/a | n/a |
| Nutex Health NUTX | Medical/Nursing Services | $1.24B | -12% | +32% | +7% | 43% | 7.2× |
| SpyGlass Pharma SGP | Biotechnology | $1.24B | +50% | +58% | n/a | n/a | n/a |
| Silence Therapeutics PLC Sponsored ADR SLN | Miscellaneous Commercial Services | $1.23B | +107% | +184% | -97% | -10,478% | n/a |
| Omeros OMER | Pharmaceuticals: Major | $1.22B | -12% | +14% | n/a | -190% | 7.7× |
| Vor Biopharma VOR | Biotechnology | $1.22B | +4% | +17% | n/a | n/a | n/a |
| COMPASS Pathways Plc Sponsored ADR CMPS | Biotechnology | $1.22B | -25% | -13% | n/a | n/a | n/a |
| Amphastar Pharmaceuticals AMPH | Pharmaceuticals: Major | $1.21B | +10% | +50% | +1% | 16% | 8.9× |
| UroGen Pharma URGN | Biotechnology | $1.21B | -33% | -16% | +159% | -12% | 13.9× |
| GoodRx GDRX | Medical/Nursing Services | $1.20B | +4% | +20% | -2% | 12% | 10.4× |
| PROCEPT BioRobotics PRCT | Medical Specialties | $1.18B | +15% | -19% | +23% | -34% | n/a |
| Tandem Diabetes Care TNDM | Medical Specialties | $1.18B | +8% | +9% | +4% | -4% | n/a |
| Rapport Therapeutics RAPP | Biotechnology | $1.17B | -18% | -36% | n/a | -838% | n/a |
| Alphatec ATEC | Medical Specialties | $1.15B | -28% | -1% | +15% | -3% | 15.0× |
| Seaport Therapeutics SPTX | Pharmaceuticals: Major | $1.15B | +20% | +34% | n/a | n/a | n/a |
| IRadimed IRMD | Medical Specialties | $1.10B | 0% | 0% | +11% | 32% | 36.0× |
| Freenome FRNM | Medical Specialties | $1.09B | -36% | n/a | n/a | n/a | n/a |
| SI-BONE SIBN | Medical Specialties | $1.09B | +29% | +98% | +14% | -8% | n/a |
| Janux Therapeutics JANX | Biotechnology | $1.08B | -5% | +24% | +5,367% | -598% | n/a |
| BellRing Brands BRBR | Beverages: Non-Alcoholic | $1.07B | +15% | -11% | +6% | 13% | 7.6× |
| Integra LifeSciences IART | Medical Specialties | $1.04B | 0% | -4% | +1% | 12% | 5.8× |
| Ceribell CBLL | Medical Specialties | $1.03B | +15% | +32% | +31% | -70% | n/a |
| Verastem VSTM | Biotechnology | $1.02B | +4% | +72% | +3,996% | -183% | n/a |
| Harrow HROW | Pharmaceuticals: Major | $1.01B | -12% | -30% | +21% | 2% | 21.9× |
| AdaptHealth AHCO | Medical/Nursing Services | $1.00B | +1% | +8% | -3% | 3% | n/a |
| Castle Biosciences CSTL | Medical Specialties | $993M | -4% | +64% | +3% | -9% | n/a |
| Savara SVRA | Pharmaceuticals: Major | $992M | 0% | -8% | n/a | n/a | n/a |
| Alto Neuroscience ANRO | Biotechnology | $987M | +5% | +4% | n/a | n/a | n/a |
| Artivion AORT | Medical Specialties | $985M | -5% | -20% | +16% | 7% | 3,912.9× |
| MoonLake Immunotherapeutics MLTX | Pharmaceuticals: Major | $981M | +9% | -32% | n/a | n/a | n/a |
| CryoPort CYRX | Air Freight/Couriers | $967M | +13% | +40% | -8% | -21% | n/a |
| Jade Biosciences JBIO | Biotechnology | $958M | +6% | -42% | n/a | n/a | n/a |
| Immatics IMTX | Pharmaceuticals: Major | $952M | -14% | -44% | -65% | -556% | n/a |
| City Therapeutics CTY | Pharmaceuticals: Major | $944M | n/a | n/a | +388% | -442% | n/a |
| Odyssey Therapeutics ODTX | Biotechnology | $924M | +6% | n/a | -33% | -5,415% | n/a |
| Oric Pharmaceuticals ORIC | Pharmaceuticals: Major | $914M | -27% | 0% | n/a | n/a | n/a |
| Monte Rosa Therapeutics GLUE | Biotechnology | $902M | +2% | -45% | -84% | -633% | n/a |
| Bioventus BVS | Medical Specialties | $894M | -16% | +1% | +4% | 10% | 13.1× |
| Corvus Pharmaceuticals CRVS | Pharmaceuticals: Major | $887M | +3% | -32% | n/a | n/a | n/a |
| Aktis Oncology AKTS | Pharmaceuticals: Major | $880M | -11% | -15% | +337% | -1,150% | n/a |
| MeiraGTx MGTX | Biotechnology | $864M | -14% | -8% | +948% | 46% | n/a |
| Syndax Pharmaceuticals SNDX | Biotechnology | $859M | -44% | -56% | +160% | -62% | n/a |
| Beta Bionics BBNX | Medical Specialties | $854M | -10% | +63% | +44% | -73% | n/a |
| Prime Medicine PRME | Biotechnology | $843M | +30% | +45% | -18% | -4,825% | n/a |
| Latigo Biotherapeutics LTGO | Pharmaceuticals: Major | $835M | -15% | n/a | n/a | n/a | n/a |
| OrthoPediatrics KIDS | Medical Specialties | $829M | +46% | +78% | +16% | -8% | n/a |
| Alumis ALMS | Pharmaceuticals: Major | $805M | -23% | -27% | -63% | -5,480% | n/a |
| Annexon ANNX | Pharmaceuticals: Major | $796M | +5% | -26% | n/a | n/a | n/a |
| Lexicon Pharmaceuticals LXRX | Pharmaceuticals: Major | $792M | +1% | -11% | -29% | -131% | n/a |
| Collegium Pharmaceutical COLL | Pharmaceuticals: Major | $788M | +10% | -36% | +14% | 20% | 3.4× |
| Varex Imaging VREX | Medical Specialties | $783M | +15% | -10% | +5% | 8% | 20.3× |
| Bambusa Therapeutics BBTX | Pharmaceuticals: Major | $783M | n/a | n/a | n/a | n/a | n/a |
| InMode INMD | Medical Specialties | $767M | -5% | -5% | -7% | 18% | 10.1× |
| Ginkgo Bioworks DNA | Medical/Nursing Services | $760M | 0% | +26% | -52% | -258% | n/a |
| Cytek Biosciences CTKB | Medical Specialties | $758M | +9% | +26% | +5% | -22% | n/a |
| Rigel Pharmaceuticals RIGL | Pharmaceuticals: Major | $741M | -19% | +52% | +3% | 31% | 11.9× |
| QuidelOrtho QDEL | Medical Specialties | $734M | -14% | -1% | -5% | -2% | 12.0× |
| OmniAb OABI | Miscellaneous Commercial Services | $734M | -3% | +29% | +91% | -116% | n/a |
| Cullinan Therapeutics CGEM | Pharmaceuticals: Major | $728M | -27% | -22% | n/a | n/a | n/a |
| Ironwood Pharmaceuticals IRWD | Pharmaceuticals: Major | $725M | +13% | +4% | +26% | 61% | 3.3× |
| Arbutus Biopharma ABUS | Pharmaceuticals: Major | $724M | -13% | -16% | +1,079% | 81% | n/a |
| Ardelyx ARDX | Pharmaceuticals: Major | $724M | -12% | -58% | +18% | -8% | 225.1× |
| Mesa Laboratories MLAB | Medical Specialties | $718M | +2% | +23% | +3% | 9% | 12.6× |
| Sana Biotechnology SANA | Biotechnology | $709M | -15% | -32% | n/a | n/a | n/a |
| Solid Biosciences SLDB | Biotechnology | $707M | -3% | -9% | n/a | n/a | n/a |
| Pacific Biosciences of California PACB | Medical Specialties | $701M | -2% | +60% | +2% | -102% | n/a |
| Attovia Therapeutics ATTO | Biotechnology | $697M | -6% | +744% | n/a | -4,975% | n/a |
| Sagimet Biosciences SGMT | Pharmaceuticals: Major | $693M | +10% | +28% | n/a | n/a | n/a |
| Achieve Life Sciences ACHV | Pharmaceuticals: Major | $692M | -7% | +29% | n/a | n/a | n/a |
| Zevra Therapeutics ZVRA | Pharmaceuticals: Major | $690M | +5% | +4% | +75% | 31% | 11.8× |
| Nuvectis Pharma NVCT | Pharmaceuticals: Major | $683M | +4% | +79% | n/a | n/a | n/a |
| Aura Biosciences AURA | Biotechnology | $680M | +1% | -22% | n/a | n/a | n/a |
| 4D Molecular Therapeutics FDMT | Biotechnology | $677M | -4% | +21% | +278,712% | -214% | n/a |
| ArriVent BioPharma AVBP | Pharmaceuticals: Other | $673M | -18% | -54% | n/a | n/a | n/a |
| GMR Solutions GMRS | Medical/Nursing Services | $672M | +18% | n/a | -4% | 14% | 8.0× |
| Candel Therapeutics CADL | Biotechnology | $670M | -9% | +5% | n/a | n/a | n/a |
| Immix Biopharma IMMX | Pharmaceuticals: Major | $668M | -13% | -17% | n/a | n/a | n/a |
| Wave Life Sciences WVE | Biotechnology | $664M | -3% | -53% | -35% | -321% | n/a |
| Fulgent Genetics FLGT | Medical/Nursing Services | $653M | +14% | +49% | +7% | -36% | n/a |
| Kura Oncology KURA | Biotechnology | $647M | -31% | -23% | -7% | -412% | n/a |
| Olema Pharmaceuticals OLMA | Pharmaceuticals: Major | $641M | -6% | -51% | n/a | n/a | n/a |
| Design Therapeutics DSGN | Biotechnology | $639M | -11% | -28% | n/a | n/a | n/a |
| Geron GERN | Biotechnology | $636M | -19% | -29% | +19% | -8% | 16.7× |
| Apnimed APMD | Biotechnology | $629M | -17% | n/a | +380% | -140% | n/a |
| Adlai Nortye Ltd. Sponsored ADR ANL | Miscellaneous Commercial Services | $619M | -34% | -23% | n/a | -134% | n/a |
| Aclaris Therapeutics ACRS | Pharmaceuticals: Major | $604M | +3% | -21% | -51% | -1,040% | n/a |
| Climb Bio CLYM | Biotechnology | $591M | -5% | -10% | n/a | n/a | n/a |
| Tactile Systems Technology TCMD | Medical Specialties | $583M | +18% | +1% | +14% | 9% | 20.8× |
| Bicara Therapeutics BCAX | Pharmaceuticals: Major | $572M | -50% | -62% | n/a | n/a | n/a |
| NRC Health NRC | Services to the Health Industry | $572M | +27% | +38% | +3% | 11% | 26.1× |
| Faeth Therapeutics FTH | Biotechnology | $570M | -14% | -6% | n/a | n/a | n/a |
| Myriad Genetics MYGN | Medical Specialties | $566M | +41% | +38% | -3% | -11% | n/a |
| Anbio Biotechnology NNNN | Medical Specialties | $560M | -16% | -85% | +10% | 67% | n/a |
| Ovid Therapeutics OVID | Pharmaceuticals: Major | $557M | +22% | +2% | -76% | -3,687% | n/a |
| Sight Sciences SGHT | Medical Specialties | $555M | +4% | -14% | +9% | -33% | n/a |
| Anteris Technologies Global AVR | Medical Specialties | $555M | -14% | -14% | -10% | -4,738% | n/a |
| Entera Bio ENTX | Pharmaceuticals: Major | $546M | +26% | +142% | -100% | n/a | n/a |
| Jin Medical International ZJYL | Medical Specialties | $532M | +58% | +53% | -14% | 2% | n/a |
| Capricor Therapeutics CAPR | Pharmaceuticals: Major | $523M | +12% | -73% | -100% | n/a | n/a |
| SBC Medical SBC | Miscellaneous Commercial Services | $518M | -6% | +58% | -7% | 37% | 10.3× |
| Delcath Systems DCTH | Medical Specialties | $518M | -1% | +30% | +36% | -2% | n/a |
| Evolent Health EVH | Miscellaneous Commercial Services | $518M | +16% | +10% | -4% | -1% | 12.1× |
| AVITA Medical RCEL | Medical Specialties | $513M | +24% | +304% | +1% | -47% | n/a |
| Indaptus Therapeutics INDP | Pharmaceuticals: Major | $510M | +40% | +64% | n/a | n/a | n/a |
| Neurogene NGNE | Biotechnology | $506M | -4% | -18% | -100% | n/a | n/a |
| DiaMedica Therapeutics DMAC | Biotechnology | $505M | +17% | +48% | n/a | n/a | n/a |
| Gyre Therapeutics GYRE | Pharmaceuticals: Major | $505M | -30% | -36% | +17% | -11% | n/a |
| REGENXBIO RGNX | Pharmaceuticals: Major | $503M | -6% | -28% | +12% | -94% | n/a |
| Crescent Biopharma CBIO | Biotechnology | $503M | -4% | -28% | n/a | -1,418% | n/a |
| Strata Critical Medical SRTA | Medical/Nursing Services | $497M | +24% | 0% | +23% | -4% | 67.4× |